Fortrea Holdings (FTRE) Operating Expenses (2022 - 2026)
Fortrea Holdings (FTRE) reported Operating Expenses of $639.9 million for Q1 2026, down 45.37% on a YoY basis from $1.2 billion in Q1 2025, and down 5.07% quarter-over-quarter from $674.1 million in Q4 2025.
Fortrea Holdings (FTRE) Operating Expenses (2022 - 2026) Analysis & Trends
Fortrea Holdings has reported Operating Expenses for 5 years, with the latest figure at $639.9 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Expenses fell 45.37% year-over-year to $639.9 million; the trailing twelve-month figure through Mar 2026 stood at $3.1 billion (down 7.98% YoY), and the FY2025 full-year result was $3.6 billion, up 25.81% from the prior year.
- Operating Expenses for Q1 2026 stood at $639.9 million, down from $674.1 million in the prior quarter.
- The five-year high for Operating Expenses was $1.2 billion in Q1 2025, with the low at $488.3 million in Q4 2022.
- Historically, Operating Expenses has averaged $738.0 million across 5 years, with a median of $701.5 million in 2023.
- Annual changes were most pronounced in 2025 — Operating Expenses jumped 67.46% — and 2026, when it slumped 45.37%.
- Fortrea Holdings' Operating Expenses stood at $488.3 million in 2022, then soared by 50.26% to $733.7 million in 2023, then rose by 2.58% to $752.6 million in 2024, then decreased by 10.43% to $674.1 million in 2025, then dropped by 5.07% to $639.9 million in 2026.
- The last three Operating Expenses figures came in at $639.9 million (Q1 2026), $674.1 million (Q4 2025), and $709.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn | 639.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 639.90 Mn |
| Dec 31, 2025 | 674.10 Mn |
| Sep 30, 2025 | 709.90 Mn |
| Jun 30, 2025 | 1.04 Bn |
| Mar 31, 2025 | 1.17 Bn |
| Dec 31, 2024 | 752.60 Mn |
| Sep 30, 2024 | 692.90 Mn |
| Jun 30, 2024 | 713.30 Mn |
| Mar 31, 2024 | 699.50 Mn |
| Dec 31, 2023 | 733.70 Mn |
| Sep 30, 2023 | 703.50 Mn |
| Jun 30, 2023 | 693.50 Mn |
| Mar 31, 2023 | 679.80 Mn |
| Dec 31, 2022 | 488.30 Mn |
| Sep 30, 2022 | 693.40 Mn |
| Jun 30, 2022 | 721.90 Mn |